0:00
Video Narration
12
0

Description

AMIIF
The Mexican Association of Pharmaceutical Research Industries

Vocal Characteristics

Language

English

Voice Age

Young Adult (18-35)

Accents

North American (General)

Transcript

Note: Transcripts are generated using speech recognition software and may contain errors.
clinical research in Mexico. It's possible clinical research is a process that requires great dedication and contributes to the development of new treatments. It enables the understanding of safer and more efficient ways to prevent control or revert diseases, as well as how to benefit the greatest number of patients with new treatment options. In Mexico, we have researchers qualified to implement clinical research projects in line with the highest regulation standards and with experience in every therapeutic area. We have enormous potential to recruit patients in a large scale, thanks to the more than 120 million inhabitants and a diverse epidemiological profile that includes communicable and non communicable chronic degenerative and low prevalence diseases. Additionally, the health care system offers diverse options to carry out clinical research, competitive costs and appropriate specialization levels. For every research stage. More than 190 committees on research ethics, as well as qualified hospital infrastructure and systems to monitor patients. The regulatory framework led by the Federal Committee for the Protection Against Sanitary Risks, Coffee breeze, permits the execution of every stage of the clinical research as well as applying innovative methods that will benefit patients health. Moreover, Kofi Breeze holds international certifications such as the National Regulatory Authorities for medicines Level four granted by the World Health Organization. It is also part of the pharmaceutical inspection cooperation scheme, said Authority has one of the most competitive timeframes in Latin America for the authorization of clinical research protocols 90 days. Mexico's intellectual property legal framework is robust, which is vital for innovation and attracting investments. We have offices from the major Contract Research Organization at a global level, pharmaceutical industry, office spaces and production floors, high standard health care institutions and agents such as the National Bioethics Committee and the Tax Administration Service that enable the tasks and processes of clinical research to occur. We hold the potential to place ourselves as one of the 10 global players and clinical research. In addition, Mexico has managed to create a group which brings together public institutions and industry leaders in the area of clinical research. This group has cooperated and improving the existing processes and laying the foundation for the development of the life sciences field. Amongst its main achievements, they boast having obtained the backing of the President of the Republic and in January of 2017 UN Agreement for the Development of Clinical Research in the public health care system that deals with the most inhabitants in Mexico. The teams this agreement sparked to the involvement of other institutions looking to have similar records, which in turn resulted in the creation of the group of leaders and clinical research. Mexico is a country with great potential. Nowadays we attract a yearly investments of around $160 million we are capable of raising that figure to up to $500 million a figure that will translate into the bettering of the health care infrastructure and Maurin better therapeutic options for patients and the opportunity of being a key player in providing health care solutions. For these and other reasons, we are agree option for the development of clinical research. We await you with open arms.